Laffan MA - Search Results

1

Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

Sivapalaratnam S, Westbury SK, Stephens JC, Greene D, Downes K, Kelly AM, Lentaigne C, Astle WJ, Huizinga EG, Nurden P, Papadia S, Peerlinck K, Penkett CJ, Perry DJ, Roughley C, Simeoni I, Stirrups K, Hart DP, Tait RC, Mumford AD; NIHR BioResource; Laffan MA, Freson K, Ouwehand WH, Kunishima S, Turro E. Sivapalaratnam S, et al. Among authors: laffan ma. Blood. 2017 Jan 26;129(4):520-524. doi: 10.1182/blood-2016-08-732248. Epub 2016 Nov 14. Blood. 2017. PMID: 28064200 Free PMC article.

2

Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response.

O'Donnell J, Mumford AD, Manning RA, Laffan M. O'Donnell J, et al. Thromb Haemost. 2000 Jan;83(1):10-3. Thromb Haemost. 2000. PMID: 10669146

3

Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.

Vakalopoulou S, Mille-Baker B, Mumford A, Manning R, Laffan M. Vakalopoulou S, et al. Blood Coagul Fibrinolysis. 1999 Oct;10(7):403-8. Blood Coagul Fibrinolysis. 1999. PMID: 10695765

4

Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.

Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Mumford AD, et al. Br J Haematol. 2000 Aug;110(2):454-60. doi: 10.1046/j.1365-2141.2000.02183.x. Br J Haematol. 2000. PMID: 10971408 Free article.

5

Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.

O'Donnell J, Mumford AD, Manning RA, Laffan MA. O'Donnell J, et al. Among authors: laffan ma. Br J Haematol. 2001 Dec;115(3):687-91. doi: 10.1046/j.1365-2141.2001.03146.x. Br J Haematol. 2001. PMID: 11736955 Free article.

6

A Tyr346-->Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy.

Mumford AD, Laffan M, O'Donnell J, McVey JH, Johnson DJ, Manning RA, Kemball-Cook G. Mumford AD, et al. Br J Haematol. 2002 Aug;118(2):589-94. doi: 10.1046/j.1365-2141.2002.03617.x. Br J Haematol. 2002. PMID: 12139751 Free article.

7

Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity.

Mille-Baker B, Rezende SM, Simmonds RE, Mason PJ, Lane DA, Laffan MA. Mille-Baker B, et al. Among authors: laffan ma. Blood. 2003 Feb 15;101(4):1416-8. doi: 10.1182/blood-2002-08-2353. Epub 2002 Oct 10. Blood. 2003. PMID: 12393507 Free article.

8

Analysis and results of the recombinant factor VIIa extended-use registry.

Laffan M, O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy D, Smith OP. Laffan M, et al. Blood Coagul Fibrinolysis. 2003 Jun;14 Suppl 1:S35-8. doi: 10.1097/00001721-200306001-00009. Blood Coagul Fibrinolysis. 2003. PMID: 14567534

9

Recombinant FVIIa in the management of uncontrolled hemorrhage.

O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF, Laffan MA, Smith OP. O'Connell NM, et al. Among authors: laffan ma. Transfusion. 2003 Dec;43(12):1711-6. doi: 10.1046/j.0041-1132.2003.00577.x. Transfusion. 2003. PMID: 14641868

10

Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.

Laffan MA, Tait RC, Blatný J, Espersen K, Grabowska I, Loch-Bakoñska L, Pauzkowska A, Stasiak-Pikula E, Michalska G, Wendon J, Piotrowska K. Laffan MA, et al. Pancreas. 2005 Apr;30(3):279-84. doi: 10.1097/01.mpa.0000158026.30925.b4. Pancreas. 2005. PMID: 15782108 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page